FDA will lift warnings on hormone therapy for menopause
Digest more
Last week, China announced a 180 million metric ton purchase of U.S. soybeans and a three-year commitment to buying more. What does this mean for the farmer aid package that was being proposed prior to these developments?
In a major shift, the FDA announced it will remove long-standing black box warnings from hormone-based treatments for menopause symptoms like hot flashes. The agency now says new data show limited risks for women who begin therapy before age 60 or within a decade of menopause.